Affiliation: Erasmus University
Country: The Netherlands
- Obesity in adulthood and its consequences for life expectancy: a life-table analysisAnna Peeters
Department of Public Health, Erasmus MC, PO Box 1738, 3000 DR Rotterdam, The Netherlands
Ann Intern Med 138:24-32. 2003..Overweight and obesity in adulthood are linked to an increased risk for death and disease. Their potential effect on life expectancy and premature death has not yet been described...
- Improvements in treatment of coronary heart disease and cessation of stroke mortality rate declineAnna Peeters
Department of Public Health, Erasmus Medical Center, PO Box 1738, 3000 DR Rotterdam, Netherlands
Stroke 34:1610-4. 2003..Here we test the hypothesis that improvements in coronary heart disease (CHD) survival can explain this slowing through an increase in the number of CHD survivors at an increased risk for stroke...
- Physical activity and life expectancy with and without diabetes: life table analysis of the Framingham Heart StudyJacqueline T Jonker
Department of Public Health, Erasmus Medical Center, P.O. Box 1738, 3000 DR, Rotterdam, Netherlands
Diabetes Care 29:38-43. 2006..2 (-0.8 to 0.3) years, respectively. CONCLUSIONS: Moderately and highly active people have a longer total life expectancy and live more years free of diabetes than their sedentary counterparts but do not spend more years with diabetes...
- Effectiveness calculation in economic analysis: the case of statins for cardiovascular disease preventionOscar H Franco
Department of Public Health, Erasmus MC, University Medical Centre Rotterdam, Netherlands
J Epidemiol Community Health 60:839-45. 2006..This report aimed to evaluate the calculation of estimates of effectiveness in cost effectiveness analyses of statins for cardiovascular disease prevention...
- Adult obesity and number of years lived with and without cardiovascular diseaseM Carolina Pardo Silva
Department of Public Health, Erasmus Medical Center Rotterdam, The Netherlands
Obesity (Silver Spring) 14:1264-73. 2006..Such information is paramount for preventive and therapeutic decision-making by individuals and practitioners alike...
- Blood pressure in adulthood and life expectancy with cardiovascular disease in men and women: life course analysisOscar H Franco
Department of Public Health, Erasmus MC, University Medical Center Rotterdam, PO Box 1738, 3000 DR Rotterdam, The Netherlands
Hypertension 46:280-6. 2005..This effect is larger than estimated previously and affects both sexes similarly. Our findings underline the tremendous importance of preventing high blood pressure and its consequences in the population...
- Living healthier for longer: comparative effects of three heart-healthy behaviors on life expectancy with and without cardiovascular diseaseWilma J Nusselder
Department of Public Health, Erasmus MC, University Medical Center Rotterdam, PO Box 2040, 3000 CA Rotterdam, Rotterdam, The Netherlands
BMC Public Health 9:487. 2009..We aimed to calculate and compare the effects of non-smoking, normal weight and physical activity in middle-aged populations on life expectancy with and without cardiovascular disease...
- Adult obesity and the burden of disability throughout lifeAnna Peeters
Department of Public Health, Erasmus MC, Rotterdam, The Netherlands
Obes Res 12:1145-51. 2004..To analyze the prevalence of disability throughout life and life expectancy free of disability, associated with obesity at ages 30 to 49 years...
- Effects of physical activity on life expectancy with cardiovascular diseaseOscar H Franco
Department of Public Health, Erasmus MC University Medical Center Rotterdam, Rotterdam, The Netherlands
Arch Intern Med 165:2355-60. 2005..Our objective was to calculate the consequences of different physical activity levels after age 50 years on total life expectancy and life expectancy with and without cardiovascular disease...
- The Polymeal: a more natural, safer, and probably tastier (than the Polypill) strategy to reduce cardiovascular disease by more than 75%Oscar H Franco
Department of Public Health, Erasmus MC University Medical Centre Rotterdam, PO Box 1738, 3000 DR Rotterdam, Netherlands
BMJ 329:1447-50. 2004..The objective of this study was to identify a tastier and safer alternative to the Polypill: the Polymeal...
- Apparent and internal validity of a Monte Carlo-Markov model for cardiovascular disease in a cohort follow-up studyRogier L Nijhuis
Department of Epidemiology and Biostatistics, Erasmus Medical Center, Rotterdam, The Netherlands
Med Decis Making 26:134-44. 2006..CONCLUSIONS: The simulated events and (DF)LE estimates from the RISC model are consistent with observed data from a cohort follow-up study...
- Deprivation and systematic stroke prevention in general practice: an audit among general practitioners in the Rotterdam region, The NetherlandsJohan S de Koning
Department of Public Health, Erasmus University Rotterdam, The Netherlands
Eur J Public Health 13:340-6. 2003..To investigate differences in quality of preventive care provided by general practitioners (GPs) to patients at risk of stroke living in deprived and non-deprived neighbourhoods in the Rotterdam region...
- Cost effectiveness of statins in coronary heart diseaseOscar H Franco
Department of Public Health, Erasmus MC, University Medical Centre Rotterdam, PO Box 1738, office Ee 2006, 3000 DR Rotterdam, Netherlands
J Epidemiol Community Health 59:927-33. 2005..This article reviewed cost effectiveness analyses of statins and sought to synthesise cost effectiveness ratios for categories of risk of coronary heart disease and age...
- Successful aging: measuring the years lived with functional lossWilma J Nusselder
Department of Public Health, Erasmus MC, University Medical Centre Rotterdam, Netherlands
J Epidemiol Community Health 60:448-55. 2006..These will provide more relevant information than is currently available for individuals and societies to evaluate and choose between successful aging strategies...
- Changes in abdominal obesity and age-related macular degeneration: the Atherosclerosis Risk in Communities StudyAnna Peeters
Department of Epidemiology and Preventive Medicine, Monash University, Victoria, Australia
Arch Ophthalmol 126:1554-60. 2008..To examine the association between changes in waist-hip ratio (WHR), a measure of abdominal obesity, and age-related macular degeneration (AMD)...
- Methods of estimating years of life lost due to obesityAnna Peeters
JAMA 289:2941; author reply 2941-2. 2003
- A comparison of adiposity measures as predictors of all-cause mortality: the Melbourne Collaborative Cohort StudyJulie A Simpson
Cancer Epidemiology Centre, Council Council Victoria, and Centre for Molecular, Environmental, Genetic and Analytic Epidemiology, University of Melbourne, Level 2 723 Swanston St, Carlton, Victoria 3053, Australia
Obesity (Silver Spring) 15:994-1003. 2007..Our goal was to examine five different measures of adiposity as predictors of all-cause mortality...
- How do the Australian guidelines for lipid-lowering drugs perform in practice? Cardiovascular disease risk in the AusDiab Study, 1999-2000Lei Chen
Department of Epidemiology and Preventive Medicine, Monash University, Melbourne, Vic, Australia
Med J Aust 189:319-22. 2008....
- Anthropometric measures and absolute cardiovascular risk estimates in the Australian Diabetes, Obesity and Lifestyle (AusDiab) StudyLei Chen
Department of Epidemiology and Preventive Medicine, Monash University, Melbourne, Victoria, Australia
Eur J Cardiovasc Prev Rehabil 14:740-5. 2007..We aimed to establish the most appropriate anthropometric index and its optimal cutoff point for use as an ancillary measure in clinical practice when identifying people with increased absolute cardiovascular risk estimates...
- Substantial intentional weight loss and mortality in the severely obeseAnna Peeters
The Centre for Obesity Research and Education, Monash University, Australia
Ann Surg 246:1028-33. 2007..To compare all-cause mortality in a surgical weight loss cohort with a similarly aged, obese population-based cohort...
- Primary prevention of cardiovascular disease: cost-effectiveness comparisonOscar H Franco
Department of Public Health, University Medical Center Rotterdam, 50 Dr Molewaterplein, 3000 CA Rotterdam, Zuid Holland
Int J Technol Assess Health Care 23:71-9. 2007..The aim of this study was to evaluate the cost-effectiveness of four risk-lowering interventions (smoking cessation, antihypertensives, aspirin, and statins) in primary prevention of cardiovascular disease...
- Why don't smokers show an increased mortality risk with overweight?Anna Peeters
Obes Res 10:1092-3. 2002
- Coronary heart disease risk prediction by general practitioners in VictoriaAnna Peeters
Med J Aust 180:252. 2004
- Smoking decreases the duration of life lived with and without cardiovascular disease: a life course analysis of the Framingham Heart StudyAbdullah Al Mamun
University of Groningen, Groningen, The Netherlands
Eur Heart J 25:409-15. 2004..To compare the burden of cardiovascular disease in terms of lifetime risk and life years lived with disease between smokers and non-smokers...
- Epidemiological modelling (including economic modelling) and its role in preventive drug therapyDanny Liew
Epidemiological Modelling Unit, Department of Epidemiology and Preventive Medicine, Monash University Medical School, Alfred Hospital, Melbourne, VIC 3004, Australia
Med J Aust 177:364-7. 2002..Epidemiological modelling also allows explicit information about risks and benefits of therapy to be presented to patients, facilitating informed decision-making...